UK Merges Four NHS Centers Into New Guideline Group
The merger of four National Collaborating Centres (NCCs) that produce clinical guidelines for the NHS on a wide range of topics (chronic and acute conditions) will create the

The merger of four National Collaborating Centres (NCCs) that produce clinical guidelines for the NHS on a wide range of topics (chronic and acute conditions) will create the

This proposal represents Novartis’ only and final price revision to this offer, as May 28 is the last day on which the price can be revised. Earlier, Novartis

The trial demonstrated that in patients who received PSD502, 91% achieved an IELT of greater than one minute and 75% achieved an IELT of greater than two minutes

The recommendation was provided on the basis of data provided from pivotal phase III trial of Sutent, compared to placebo. The result demonstrated that Sutent increased time to

At a time when hospitals are looking for improvements to financial performance, Perot Systems is qualified to provide revenue cycle solutions that will help our customers achieve that

The company declared a gross profit of $67.8 million for fiscal 2009, compared to a gross profit of $84.7 million during fiscal 2008, a decrease of 20%. The

Following completion of the transaction, shares of the Irish company, Covidien plc, will begin trading on the New York Stock Exchange on June 5, 2009, under the symbol

We are thrilled about our partnership with QIAGEN, as it pairs two companies to create an industry leading product, stated Steve Frisch, senior vice president, global engineering services.

Earlier in July 2008, Bayer’s partner Johnson & Johnson filed for the approval to market Rivaroxaban. FDA has not requested any new clinical or non-clinical studies to be

The president and chief executive officer of LipoLaser Bob Arrasmith opened the first LipoLaser clinic in October of 2008, and he is already expanding into the Tri-State area